622 related articles for article (PubMed ID: 9672338)
1. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
de Boer WA; Haeck PW; Otten MH; Mulder CJ
Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
3. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
4. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
5. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
[TBL] [Abstract][Full Text] [Related]
6. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
7. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
[TBL] [Abstract][Full Text] [Related]
8. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
9. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
Vakil N; Cutler A
Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
[TBL] [Abstract][Full Text] [Related]
11. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
[TBL] [Abstract][Full Text] [Related]
12. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
[TBL] [Abstract][Full Text] [Related]
13. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
[TBL] [Abstract][Full Text] [Related]
15. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
[TBL] [Abstract][Full Text] [Related]
16. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.
Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
Helicobacter; 2007 Feb; 12(1):68-73. PubMed ID: 17241304
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
18. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T
Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
Smoot DT; Hinds T; Ashktorab H; Jagtap J; Kim KS; Scott VF
Am J Gastroenterol; 1999 Apr; 94(4):955-8. PubMed ID: 10201463
[TBL] [Abstract][Full Text] [Related]
20. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
Tam YH; Yeung CK; Lee KH
Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
